These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 19229345

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?
    Staines DR.
    Med Hypotheses; 2008; 70(2):413-8. PubMed ID: 17582695
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.
    Maduna T, Lelievre V.
    J Neurosci Res; 2016 Dec; 94(12):1472-1487. PubMed ID: 27717098
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Passage of VIP/PACAP/secretin family across the blood-brain barrier: therapeutic effects.
    Dogrukol-Ak D, Tore F, Tuncel N.
    Curr Pharm Des; 2004 Aug; 10(12):1325-40. PubMed ID: 15134484
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 12. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K, Connell TD, Higgins D.
    J Neurosci; 2002 Aug 01; 22(15):6560-9. PubMed ID: 12151535
    [Abstract] [Full Text] [Related]

  • 13. Does autoimmunity of endogenous vasoactive neuropeptides cause retinopathy in humans?
    Staines DR.
    Med Hypotheses; 2008 Aug 01; 70(1):137-40. PubMed ID: 17560049
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
    Delgado M, Ganea D.
    J Immunol; 2000 Feb 01; 164(3):1200-10. PubMed ID: 10640731
    [Abstract] [Full Text] [Related]

  • 16. Role of PACAP and VIP in astroglial functions.
    Masmoudi-Kouki O, Gandolfo P, Castel H, Leprince J, Fournier A, Dejda A, Vaudry H, Tonon MC.
    Peptides; 2007 Sep 01; 28(9):1753-60. PubMed ID: 17655978
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M, Ganea D.
    J Immunol; 2001 Jan 15; 166(2):1028-40. PubMed ID: 11145682
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M, Ganea D.
    J Immunol; 2000 Sep 15; 165(6):3051-7. PubMed ID: 10975815
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophages.
    Sun W, Tadmori I, Yang L, Delgado M, Ganea D.
    J Neuroimmunol; 2000 Jul 10; 107(1):88-99. PubMed ID: 10808055
    [Abstract] [Full Text] [Related]

  • 20. VIP and PACAP: novel approaches to brain functions and neuroprotection.
    Shioda S, Gozes I.
    Curr Pharm Des; 2011 Jul 10; 17(10):961. PubMed ID: 21524249
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.